elements
-live
Search elements, keywords, and sectors
🔎
Elements
Subjects
Pricing
Log in
Sign up
Home
/
Subjects
/
Somatostatin receptor
← Back to subjects
Current data, viewed at
Yearly
resolution.
Personal members see monthly resolution →
Keyword
keyword
Somatostatin receptor
RIS
0.002
(Research Intensity Score)
Papers
289
Top papers
EANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor- and PSMA-targeting ligands
2022 · 249 citations
Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standards for diagnostics and therapy (theranostics) of meningiomas using radiolabeled somatostatin receptor ligands: version 1.0
2024 · 66 citations
Consensus on molecular imaging and theranostics in neuroendocrine neoplasms
2021 · 248 citations
Radiomics and Artificial Intelligence in Radiotheranostics: A Review of Applications for Radioligands Targeting Somatostatin Receptors and Prostate-Specific Membrane Antigens
2024 · 54 citations
First-in-human administration of terbium-161-labelled somatostatin receptor subtype 2 antagonist ([161Tb]Tb-DOTA-LM3) in a patient with a metastatic neuroendocrine tumour of the ileum
2024 · 43 citations
Safety and dosimetry of [177Lu]Lu-DOTA-TATE in adolescent patients with somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumours, or pheochromocytomas and paragangliomas: Primary analysis of the Phase II NETTER-P study
2025 · 19 citations
Lutathera®: The First FDA- and EMA-Approved Radiopharmaceutical for Peptide Receptor Radionuclide Therapy
2019 · 417 citations
Emerging innovations in theranostics for pancreatic neuroendocrine tumors
2025 · 17 citations
Gastroenteropancreatic Neuroendocrine Tumors
2018 · 614 citations
Newest papers
Peptide receptor radionuclide therapy in neuroendocrine tumours: advances, combination strategies, and future directions
2026 · 4 citations
Case Report: Evolution of intratumoral spatial heterogeneity assessed by [68Ga]Ga-DOTA-NOC PET/CT during dinutuximab beta therapy in pediatric high-risk neuroblastoma
2026
SSTR2 receptor states and cellular metabolism modulate 177Lu-DOTATATE binding affinity
2026
18F-FDG and 68Ga-FAPI PET/CT Imaging in a Patient with High-Grade Meningioma: A Case Report
2026
Molecular Imaging and Radioligand Therapies in Pheochromocytomas and Paragangliomas
2026
Cross-Species Quantitative Benchmarking of SSTR2 Radioligands in Fresh-Frozen Brain Sections: An Adaptable Framework for Radiopharmaceutical Development
2026
FAP-Targeted Radionuclide Therapy: Mechanisms, Clinical Applications, and Combination Strategies
2026
Feasibility of treating neuroendocrine prostate cancer with anti-SSTR radioligands: A systematic review of imaging and treatment studies
2026
Radionuclide and Theranostic Therapies
2026
Browse all papers →
Somatostatin receptor's history
Research intensity over time
Yearly
Personal members see monthly resolution →
Data temporarily unavailable — please try again shortly.
Close ✕
Somatostatin receptor's papers
Ordered by current research-activity contribution.
Loading…
Close ✕
Read full text ↗
Share
Share on X
Share on Facebook
Share on LinkedIn
Copy link